Upgrade to SI Premium - Free Trial

Bright Minds Biosciences (DRUG)

66.55 -2.45 (3.55%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/25 *Est.)

Latest Headlines

Form 6-K BRIGHT MINDS BIOSCIENCES For: Mar 31 June 3, 2026 6:05 AM - SEC Filing Form 6-K BRIGHT MINDS BIOSCIENCES For: Jan 20 June 2, 2026 11:39 AM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG) June 2, 2026 6:57 AM - StreetInsider Form 6-K BRIGHT MINDS BIOSCIENCES For: May 26 May 28, 2026 6:03 AM - SEC Filing Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference May 26, 2026 7:18 PM - Globe NewsWire Bright Minds Biosciences Inc. (DRUG) PT Raised to $220 at Piper Sandler May 20, 2026 6:52 AM - StreetInsider Form 6-K BRIGHT MINDS BIOSCIENCES For: Mar 31 May 20, 2026 6:01 AM - SEC Filing Form SCHEDULE 13G BRIGHT MINDS BIOSCIENCES Filed by: Vestal Point Capital, LP May 15, 2026 5:05 PM - SEC Filing Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: JANUS HENDERSON GROUP PLC May 15, 2026 12:37 PM - SEC Filing Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: JANUS HENDERSON GROUP PLC May 15, 2026 12:37 PM - SEC Filing Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: Vivo Opportunity Fund Holdings, L.P. May 12, 2026 9:44 PM - SEC Filing Form SCHEDULE 13G/A BRIGHT MINDS BIOSCIENCES Filed by: Cormorant Asset Management, LP April 30, 2026 4:15 PM - SEC Filing Form 4 BRIGHT MINDS BIOSCIENCES For: Apr 28 Filed by: Chen Bihua April 30, 2026 4:13 PM - SEC Filing Jefferies Starts Bright Minds Biosciences Inc. (DRUG) at Buy April 13, 2026 3:21 AM - StreetInsider BTIG Reiterates Buy Rating on Bright Minds Biosciences Inc. (DRUG) March 30, 2026 5:08 AM - StreetInsider Full Article List